PPARγ recruitment to active ERK during memory consolidation is required for alzheimer's disease-related cognitive enhancement

Journal of Neuroscience

Volumn 34, Issue 11, 2014, Pages 4054-4063

  Jahrling, Jordan B ^a   Hernandez, Caterina M ^a   Denner, Larry ^a,b   Dineley, Kelly T ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Alzheimer's; Hippocampus; In vitro reconstitution; Protein complex; Transgenic

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; GLUTATHIONE TRANSFERASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; NEOSPORIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RECOMBINANT PROTEIN; ROSIGLITAZONE;

ALZHEIMER DISEASE; AMYLOIDOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COGNITIVE DEFECT; CONDITIONING; CONTROLLED STUDY; FEAR; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOPRECIPITATION; INFLAMMATION; MALE; MEMORY CONSOLIDATION; MOUSE; NONHUMAN; PAIN; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN ISOLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ALZHEIMER'S; HIPPOCAMPUS; IN VITRO RECONSTITUTION; PROTEIN COMPLEX; TRANSGENIC;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANILIDES; ANIMALS; COGNITION; FEMALE; HIPPOCAMPUS; HUMANS; INJECTIONS, INTRAVENTRICULAR; MALE; MAP KINASE SIGNALING SYSTEM; MEMORY; MICE; MICE, INBRED STRAINS; MICE, TRANSGENIC; MIDDLE AGED; NOOTROPIC AGENTS; PHOSPHORYLATION; PPAR GAMMA; THIAZOLIDINEDIONES;

EID: 84896753835     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.4024-13.2014     Document Type: Article

References (66)

1. Ahi J, Radulovic J, Spiess J (2004) The role of hippocampal signaling cascades in consolidation of fear memory. Behav Brain Res 149:17-31. CrossRef Medline
2. Atkins CM, Selcher JC, Petraitis JJ, Trzaskos JM, Sweatt JD (1998) The MAPK cascade is required for mammalian associative learning. Nat Neurosci 1:602-609. CrossRef Medline
3. Becker RE, GreigNH (2013) Fire in the ashes: can failed Alzheimer's disease drugs succeed with second chances? Alzheimers Dement 9:50-57. CrossRef Medline
4. Bjorklund NL, Sadagoparamanujam VM, Taglialatela G (2012) Selective, quantitative measurement of releasable synaptic zinc in human autopsy hippocampal brain tissue from Alzheimer's disease patients. J Neurosci Methods 203:146-151. CrossRef Medline
5. Bugge A, Grøntved L, Aagaard MM, Borup R, Mandrup S (2009) The PPAR-gamma2 a/B-domain plays a gene-specific role in transactivation and cofactor recruitment. Mol Endocrinol 23:794-808. CrossRef Medline
6. Burgermeister E, Seger R (2007) Mapk kinases as nucleo-cytoplasmic shuttles for Ppargamma. Cell Cycle 6:1539-1548. CrossRef Medline
7. Canagarajah BJ, Khokhlatchev A, Cobb MH, Goldsmith EJ (1997) Activation mechanism of the map kinase Erk2 by dual phosphorylation. Cell 90:859-869. CrossRef Medline
8. Choi JH, Banks AS, Kamenecka TM, Busby SA, Chalmers MJ, Kumar N, Kuruvilla DS, Shin Y, He Y, Bruning JB, Marciano DP, Cameron MD, Laznik D, Jurczak MJ, Schurer SC, Vidović D, Shulman GI, Spiegelman BM, Griffin PR (2011) Antidiabetic actions of a non-agonist Ppargamma ligand blocking Cdk5-mediated phosphorylation. Nature 477: 477-481. CrossRef Medline
9. Clark WG, Vivonia CA, Baxter CF (1968) Accurate freehand injection into the lateral brain ventricle of the conscious mouse. J Appl Physiol 25:319-321. Medline
10. Cohen J (1992) A power primer. Psychol Bull 112:155-159. CrossRef Medline
11. Craft S (2012) Alzheimer disease: insulin resistance andAD-extending the translational path. Nat Rev Neurol 8:360-362. CrossRef Medline
12. Craft S, Baker LD, Montine TJ, Minoshima S, Watson GS, Claxton A, Arbuckle M, Callaghan M, Tsai E, Plymate SR, Green PS, Leverenz J, Cross D, Gerton B (2012) Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Arch Neurol 69:29-38. CrossRef Medline
13. Denner LA, Rodriguez-Rivera J, Haidacher SJ, Jahrling JB, Carmical JR, Hernandez CM, Zhao Y, Sadygov RG, Starkey JM, Spratt H, Luxon BA, Wood TG, Dineley KT (2012) Cognitive enhancement with rosiglitazone links the hippocampal PPARγ and ERK MAPK signaling pathways. J Neurosci 32:16725-16735a. CrossRef Medline
14. Dineley KT, Xia X, Bui D, Sweatt JD, Zheng H (2002) Accelerated plaque accumulation, associative learning deficits, and up-regulation of Alpha 7 nicotinic receptor protein in transgenic mice co-expressing mutant human presenilin 1 and amyloid precursor proteins. J Biol Chem 277: 22768-22780. CrossRef Medline
15. Dineley KT, Hogan D, Zhang WR, Taglialatela G (2007) Acute inhibition of calcineurin restores associative learning and memory in Tg2576 APP transgenic mice. Neurobiol Learn Mem 88:217-224. CrossRef Medline
16. Escribano L, Simón AM, Pérez-Mediavilla A, Salazar-Colocho P, Del Río J, Frechilla D (2009) Rosiglitazone reverses memory decline and hippocampal glucocorticoid receptor down-regulation in an Alzheimer's disease mouse model. Biochem Biophys Res Commun 379:406-410. CrossRef Medline
17. Frödin M, Gammeltoft S (1999) Role and regulation of 90 kDa ribosomal S6 kinase (Rsk) in signal transduction. Mol Cell Endocrinol 151:65-77. CrossRef Medline
18. Garai Á, Zeke A, Gógl G, Töro{double acute} I, Fördo{double acute}s F, Blankenburg H, Bárkai T, Varga J, Alexa A, Emig D, Albrecht M, Reményi A (2012) Specificity of linear motifs that bind to a common mitogen-activated protein kinase docking groove. Sci Signal 5:ra74. CrossRef Medline
19. Gavin AC, Nebreda AR (1999) A map kinase docking site is required for phosphorylation and activation of P90(Rsk)/MAPKAP kinase-1. Curr Biol 9:281-284. CrossRef Medline
20. Guzowski JF, McGaugh JL (1997) Antisense oligodeoxynucleotidemediated disruption of hippocampal camp response element binding protein levels impairs consolidation of memory for water maze training. Proc Natl Acad Sci U S A 94:2693-2698. CrossRef Medline
21. Hamann S, Monarch ES, Goldstein FC (2002) Impaired fear conditioning in Alzheimer's disease. Neuropsychologia 40:1187-1195. CrossRef Medline
22. Hashimoto R, Yu J, Koizumi H, Ouchi Y, Okabe T (2012) Ginsenoside Rb1 prevents Mpp(+)-induced apoptosis in Pc12 cells by stimulating estrogen receptors with consequent activation of ERK1/2, Akt and inhibition of SAPK/Jnk, P38 MAPK. Evid Based Complement Alternat Med 2012: 693717. CrossRef Medline
23. Hoefer M, Allison SC, Schauer GF, Neuhaus JM, Hall J, Dang JN, Weiner MW, Miller BL, Rosen HJ (2008) Fear conditioning in frontotemporal lobar degeneration and Alzheimer's disease. Brain 131:1646-1657. CrossRef Medline
24. Hort J, Laczó J, Vyhnálek M, Bojar M, Bures J, Vlcek K (2007) Spatial navigation deficit in amnestic mild cognitive impairment. Proc Natl Acad Sci U S A 104:4042-4047. CrossRef Medline
25. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G (1996) Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274:99-102. CrossRef Medline
26. Hyman BT, Elvhage TE, Reiter J (1994) Extracellular signal regulated kinases. Localization of protein and MRNA in the human hippocampal formation in Alzheimer's disease. Am J Pathol 144:565-572. Medline
27. Jacobs D, Glossip D, Xing H, Muslin AJ, Kornfeld K (1999) Multiple docking sites on substrate proteins form a modular system that mediates recognition by Erk Map kinase. Genes Dev 13:163-175. CrossRef Medline
28. Jiang Q, Heneka M, Landreth GE (2008) The role of peroxisome proliferator-activated receptor-Gamma (Ppargamma) in Alzheimer's disease: therapeutic implications. CNS Drugs 22:1-14. CrossRef Medline
29. Khan SH, Awasthi S, Guo C, Goswami D, Ling J, Griffin PR, Simons SS Jr, Kumar R (2012) Binding of the N-terminal region of coactivator Tif2 to the intrinsically disordered Af1 domain of the glucocorticoid receptor is accompanied by conformational reorganizations. J Biol Chem 287: 44546-44560. CrossRef Medline
30. Landreth G, Jiang Q, Mandrekar S, Heneka M (2008) Ppargamma agonists as therapeutics for the treatment of Alzheimer's disease. Neurotherapeutics 5:481-489. CrossRef Medline
31. Lee T, Hoofnagle AN, Kabuyama Y, Stroud J, Min X, Goldsmith EJ, Chen L, Resing KA, Ahn NG (2004) Docking motif interactions in Map kinases revealed by hydrogen exchange mass spectrometry. Mol Cell 14:43-55. CrossRef Medline
32. Mandrekar-Colucci S, Landreth GE (2011) Nuclear receptors as therapeutic targets for Alzheimer's disease. Expert Opin Ther Targets 15:1085-1097. CrossRef Medline
33. Mandrekar-Colucci S, Karlo JC, Landreth GE (2012) Mechanisms underlying the rapid peroxisome proliferator-activated receptor-γ-mediated amyloid clearance and reversal of cognitive deficits in a murine model of Alzheimer's disease. J Neurosci 32:10117-10128. CrossRef Medline
34. McGaugh JL (2000) Memory-a century of consolidation. Science 287: 248-251. CrossRef Medline
35. Miyamoto-Sato E, Fujimori S, Ishizaka M, Hirai N, Masuoka K, Saito R, Ozawa Y, Hino K, Washio T, Tomita M, Yamashita T, Oshikubo T, Akasaka H, Sugiyama J, Matsumoto Y, Yanagawa H (2010) A comprehensive resource of interacting protein regions for refining human transcription factor networks. PLoS One 5:e9289. CrossRef Medline
36. Morice E, Farley S, Poirier R, Dallerac G, Chagneau C, Pannetier S, Hanauer A, Davis S, Vaillend C, Laroche S (2013) Defective synaptic transmission and structure in the dentate gyrus and selective fear memory impairment in the Rsk2 mutant mouse model of Coffin-Lowry syndrome. Neurobiol Dis 58:156-168. CrossRef Medline
37. Paxinos G, Watson C, Pennisi M, Topple A (1985) Bregma, lambda and the interaural midpoint in stereotaxic surgery with rats of different sex, strain and weight. J Neurosci Methods 13:139-143. CrossRef Medline
38. Pedersen WA, McMillan PJ, Kulstad JJ, Leverenz JB, Craft S, Haynatzki GR (2006) Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice. Exp Neurol 199:265-273. CrossRef Medline
39. Reményi A, Good MC, Bhattacharyya RP, LimWA (2005) The role of docking interactions in mediating signaling input, output, and discrimination in the yeast MAPK network. Mol Cell 20:951-962. CrossRef Medline
40. Revest JM, Di Blasi F, Kitchener P, Rougé-Pont F, Desmedt A, Turiault M, Tronche F, Piazza PV (2005) The MAPK pathway and Egr-1 mediate stress-related behavioral effects of glucocorticoids. Nat Neurosci 8:664-672. CrossRef Medline
41. Risner ME, Saunders AM, Altman JF, Ormandy GC, Craft S, Foley IM, Zvartau-Hind ME, Hosford DA, Roses AD (2006) Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease. Pharmacogenomics J 6:246-254. CrossRef Medline
42. Rodriguez-Rivera J, Denner L, Dineley KT (2011) Rosiglitazone reversal of Tg2576 cognitive deficits is independent of peripheral gluco-regulatory status. Behav Brain Res 216:255-261. CrossRef Medline
43. Ryan KK, Li B, Grayson BE, Matter EK, Woods SC, Seeley RJ (2011) A role for central nervous system PPAR-gamma in the regulation of energy balance. Nat Med 17:623-626. CrossRef Medline
44. Sato T, Hanyu H, Hirao K, Kanetaka H, Sakurai H, Iwamoto T (2011) Efficacy of PPAR-gamma agonist pioglitazone in mild Alzheimer disease. Neurobiol Aging 32:1626-1633. CrossRef Medline
45. Selcher JC, Nekrasova T, Paylor R, Landreth GE, Sweatt JD (2001) Mice lacking the ERK1 isoform of MAP kinase are unimpaired in emotional learning. Learn Mem 8:11-19. CrossRef Medline
46. Shalin SC, Zirrgiebel U, Honsa KJ, Julien JP, Miller FD, Kaplan DR, Sweatt JD (2004) Neuronal MEK is important for normal fear conditioning in mice. J Neurosci Res 75:760-770. CrossRef Medline
47. Sheridan DL, Kong Y, Parker SA, Dalby KN, Turk BE (2008) Substrate dis-crimination among mitogen-activated protein kinases through distinct docking sequence motifs. J Biol Chem 283:19511-19520. CrossRef Medline
48. Smith JA, Poteet-Smith CE, Malarkey K, Sturgill TW (1999) Identification of an extracellular signal-regulated kinase (ERK) docking site in ribosomal S6 kinase, a sequence critical for activation by ERK in vivo. J Biol Chem 274:2893-2898. CrossRef Medline
49. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, et al. (2011) Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association Workgroups on Diagnostic Guidelines for Alzheimer's Disease. Alzheimers Dement 7:280-292. CrossRef Medline
50. Stockhorst U, de Fries D, Steingrueber HJ, Scherbaum WA (2004) Insulin and the CNS: effects on food intake, memory, and endocrine parameters and the role of intranasal insulin administration in humans. Physiol Behav 83:47-54. CrossRef Medline
51. Strawhecker JM, Betz NA, Neades RY, Houser W, Pelling JC (1989) Binding of the 97 kDa glucocorticoid receptor to the 5 upstream flanking region of the mouse C-Ha-Ras oncogene. Oncogene 4:1317-1322. Medline
52. Sweatt JD (2004) Mitogen-activated protein kinases in synaptic plasticity and memory. Curr Opin Neurobiol 14:311-317. CrossRef Medline
53. Taglialatela G, Hogan D, Zhang WR, Dineley KT (2009) Intermediate-and long-term recognition memory deficits in Tg2576 mice are reversed with acute calcineurin inhibition. Behav Brain Res 200:95-99. CrossRef Medline
54. Talbot K, Wang HY, Kazi H, Han LY, Bakshi KP, Stucky A, Fuino RL, Kawaguchi KR, Samoyedny AJ, Wilson RS, Arvanitakis Z, Schneider JA, Wolf BA, Bennett DA, Trojanowski JQ, Arnold SE (2012) Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, Irs-1 dysregulation, and cognitive decline. J Clin Invest 122:1316-1338. CrossRef Medline
55. Thies W, Bleiler L (2013) 2013 Alzheimer's disease facts and figures. Alzheimers Dement 9:208-245. CrossRef Medline
56. Trifilieff P, Calandreau L, Herry C, Mons N, Micheau J (2007) Biphasic Erk1/2 activation in both the hippocampus and amygdala may reveal a system consolidation of contextual fear memory. Neurobiol Learn Mem 88:424-434. CrossRef Medline
57. Trojanowski JQ, Mawal-Dewan M, Schmidt ML, Martin J, Lee VM (1993) Localization of the mitogen activated protein kinase ERK2 in Alzheimer's disease neurofibrillary tangles and senile plaque neurites. Brain Res 618: 333-337. CrossRef Medline
58. van Himbergen TM, Beiser AS, Ai M, Seshadri S, Otokozawa S, Au R, Thongtang N, Wolf PA, Schaefer EJ (2012) Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and Alzheimer disease: results from the Framingham Heart Study. Arch Neurol 69:594-600. CrossRef Medline
59. Vecsey CG, Hawk JD, Lattal KM, Stein JM, Fabian SA, Attner MA, Cabrera SM, McDonough CB, Brindle PK, Abel T, Wood MA (2007) Histone deacetylase inhibitors enhance memory and synaptic plasticity via CREB: CBP-dependent transcriptional activation. J Neurosci 27:6128-6140. CrossRef Medline
60. Vicent GP, Zaurin R, Ballaré C, Nacht AS, Beato M (2009) ERK signaling and chromatin remodeling in MMTV promoter activation by progestins. Nucl Recept Signal 7:e008. CrossRef Medline
61. von Kriegsheim A, Baiocchi D, Birtwistle M, Sumpton D, Bienvenut W, Morrice N, Yamada K, Lamond A, Kalna G, Orton R, Gilbert D, Kolch W (2009) Cell fate decisions are specified by the dynamic ERK interactome. Nat Cell Biol 11:1458-1464. CrossRef Medline
62. Watson GS, Craft S (2004) Modulation of memory by insulin and glucose: neuropsychological observations in Alzheimer's disease. Eur J Pharmacol 490:97-113. CrossRef Medline
63. Watson GS, Cholerton BA, Reger MA, Baker LD, Plymate SR, Asthana S, Fishel MA, Kulstad JJ, Green PS, Cook DG, Kahn SE, Keeling ML, Craft S (2005) Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study. Am J Geriatr Psychiatry 13:950-958. Medline
64. Westerman MA, Cooper-Blacketer D, Mariash A, Kotilinek L, Kawarabayashi T, Younkin LH, Carlson GA, Younkin SG, Ashe KH (2002) The relationship between Aβ and memory in the Tg2576 mouse model of Alzheimer's disease. J Neurosci 22:1858-1867. Medline
65. Wu Z, Rosen ED, Brun R, Hauser S, Adelmant G, Troy AE, McKeon C, Darlington GJ, Spiegelman BM (1999) Cross-regulation of C/Ebp alpha and Ppar gamma controls the transcriptional pathway of adipogenesis and insulin sensitivity. Mol Cell 3:151-158. CrossRef Medline
66. Yoon S, Seger R (2006) The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions. Growth Factors 24:21-44. CrossRef Medline